Toggle Main Menu Toggle Search

Open Access padlockePrints

The Newcastle University research output collection, currently available on ePrints, will shortly be moving to a new open repository platform, Figshare. To prepare for the data migration we have paused adding new content to ePrints, and will resume once the new repository is launched. During this time you will continue to have access to ePrints (but no new content will appear). We will share updates here when available.

Outcomes of Patients With Mild Cognitive Impairment With Lewy Bodies or Alzheimer Disease at 3 and 5 Years After Diagnosis

Lookup NU author(s): Dr Calum HamiltonORCiD, Dr Paul DonaghyORCiD, Dr Rory Durcan, Dr Joanna Ciafone, Dr Kirsty OlsenORCiD, Dr Gemma Roberts, Dr Michael FirbankORCiD, Dr Louise Allan, Professor John-Paul TaylorORCiD, Professor John O'Brien, Professor Alan ThomasORCiD

Downloads


Licence

This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).


Abstract

Background and Objectives: Retrospective studies indicate that dementia with Lewy bodies (DLB) may be preceded by a mild cognitive impairment (MCI) prodrome. Research criteria for the prospective identification of MCI with Lewy bodies (MCI-LB) have been developed. We aimed to assess the prognosis of a prospectively-identified MCI-LB cohort at two key milestones, three- and five-years post-diagnosis, to examine classification stability over time, and rates of adverse outcomes (dementia or death). Methods: MCI participants were prospectively recruited from North East England and differentially classified as MCI due to Alzheimer’s disease (MCI-AD), possible MCI-LB, or probable MCI-LB. Adverse outcomes (DLB/other dementia or death) and stability of disease-specific classifications were examined in each group. Results Of 152 baseline MCI participants (54 MCI-AD, 29 possible MCI-LB, and 69 probable MCI-LB), 126 were followed for up to three years and 95 for five years. Prospective probable MCI-LB classifications were both sensitive (91%) and specific (94%) to classifications either remaining as probable MCI-LB or progressing to DLB (in some cases autopsy confirmed) for three or more years after. Classifications were at least as stable as those in MCI-AD. In this cohort with disease-specific MCI classifications, rates of progression to dementia were high: 55% of MCI-LB had developed DLB within three years. Dementia occurred in 47% of MCI-AD over the same duration (OR = 1.68, 95% CI = 0.66 – 4.26, p = 0.278). Premature death was a common competing risk, occurring in 9% of MCI-AD and 11% of MCI-LB within three years. Discussion: These findings support that prospectively-identified probable MCI-LB is a prodromal presentation of DLB, and that disease-specific classifications of MCI may reliably identify different prodromal dementias.


Publication metadata

Author(s): Hamilton CA, Donaghy PC, Durcan R, Ciafone J, Olsen K, Roberts G, Firbank M, Allan LM, Taylor JP, O'Brien JT, Thomas AJ

Publication type: Article

Publication status: Published

Journal: Neurology

Year: 2024

Volume: 103

Issue: 2

Print publication date: 23/07/2024

Online publication date: 13/06/2024

Acceptance date: 26/03/2024

Date deposited: 16/05/2024

ISSN (print): 0028-3878

ISSN (electronic): 1526-632X

Publisher: Wolters Kluwer Health

URL: https://doi.org/10.1212/WNL.0000000000209499

DOI: 10.1212/WNL.0000000000209499


Altmetrics

Altmetrics provided by Altmetric


Funding

Funder referenceFunder name
Alzheimer's Research UK
GE Healthcare
NIHR Newcastle Biomedical Research Centre

Share